{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T18:14:57Z","timestamp":1784916897523,"version":"3.55.0"},"reference-count":2,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1097\/wnf.0b013e3182a2ce3f","type":"journal-article","created":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T07:43:19Z","timestamp":1379403799000},"page":"162-165","source":"Crossref","is-referenced-by-count":10,"title":["Low Doses of Rotigotine in Patients With Antipsychotic-Induced Parkinsonism"],"prefix":"10.1097","volume":"36","author":[{"given":"Roberto","family":"Di Fabio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"De Filippis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Cafariello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Penna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Marianetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Serrao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pierelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"6","key":"R4-5-20210203","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3928\/02793695-20100506-01","article-title":"Potential adverse effects of discontinuing psychotropic drugs. Part 1: adrenergic, cholinergic, and histamine drugs.","volume":"48","year":"2010","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"issue":"1","key":"R8-5-20210203","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1755-5949.2010.00211.x","article-title":"Therapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinsons disease.","volume":"17","year":"2011","journal-title":"CNS Neurosci Ther"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0b013e3182a2ce3f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:15:34Z","timestamp":1620976534000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201309000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":2,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3182a2ce3f","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}